STING1 and neoplasm: Increasing the dose of A12-VHHkappa-STING agonist from 5 mg/kg to 10 mg/kg showed stronger inhibition of tumor growth and improved survival, but with a slight increase in body weight loss (Fig. 7E and S20C).